NASDAQ | VICL: 3.50  -0.08
investors
Investors
Home / Investors / Overview

Investor Overview

Offering true paradigm-shifting potential, Vical's efforts are shaping the future of vaccines and gene therapies, and delivering on the promise of novel preventive and therapeutic alternatives for serious and life-threatening diseases.

View all news
RECENT NEWS
May 23, 2013 Vical Appoints Richard M. Beleson and Stephen A. Sherwin, M.D., to Board of Directors
May 09, 2013 Vical Reports First Quarter 2013 Financial Results and Progress in Key Development Programs
May 07, 2013 Vical to Present at May Investor Conferences
EVENTS & PRESENTATIONS
May 20, 2013
 UBS Global Healthcare Conference
May 14, 2013
 Bank of America/Merrill Lynch 2013 Health Care Conference
View the Webcast
View all events & presentations

CONNECT WITH US

STOCK QUOTE
NASDAQ GM: VICL

Stock Quote: NASD

Price 3.50

Change -0.08

Volume 451,314

% Change -2.23%

Intraday High 3.61

52 Week High 4.74

Intraday Low 3.49

52 Week Low 2.61

Today's Open 3.55

Previous Close 3.58

May 24, 2013 04:00 PM Pricing delayed 20 minutes

CONNECT WITH US

© 2013 Vical Inc.
P. 858 646 1100 10390 Pacific Center Court, San Diego, California 92121
Designed by Mentus
Powered By Q4 Web Systems 3.8.1.5343
This link to a non-Vical website is provided as a resource. Vical assumes no responsibility for content not provided by Vical, or for practices or standards of any non-Vical websites.